Key facts
- In March 2025, 1 097 measles cases were reported by 16 countries. Eleven countries reported zero cases.
- Through its epidemic intelligence activities, ECDC has identified an additional 3 012 new cases from 15 EU/EEA countries.
- Overall, four measles-related deaths have been reported in the EU/EEA in 2025, all of them in Romania.
- There has been high measles activity overall in the EU/EEA over the last 12 months; however, the situation varies by country. Some countries have reported large and/or ongoing outbreaks, while others have reported either no sustained transmission or very low transmission.
- Outbreaks associated with imported measles cases have been reported by EU countries.
- Relevant epidemiological updates are available for some countries outside EU/EEA.
Overview
In March 2025, 1 097 measles cases were reported by 16 countries. eleven countries reported zero cases. In the most recent 12-month period, from 1 March 2024 to 28 February 2025, 30 EU/EEA Member States reported a total of 28 791 cases of measles.
Between 1 April 2024 and 31 March 2025, of the 26 222cases with known age, 11 654 (44.4%) were in children under five years of age; and 7 255 (27.7%) cases were aged 15 years or older.
The highest notification rates were observed in infants under one year of age (849.7 cases per million) and children aged 1-4 years (491.7 cases per million). Of 24 337 cases (100.0% of all cases) with a known age and vaccination status, 20 893 (85.8%) were unvaccinated, 2 185 (9.0%) were vaccinated with one dose of a measles-containing vaccine, 1 180 (4.8%) were vaccinated with two or more doses, and 48 (0.2%) were vaccinated with an unknown number of doses.
Fourteen deaths (case fatality rate (CFR): 0.1) attributable to measles were reported to ECDC during the 12-month period by Romania (13) and France (one). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases.
Complementary epidemic intelligence surveillance, with data collection conducted between 12 and 15 May 2025. Sporadic cases have been reported in Austria, Czechia, Germany, Hungary, Italy, the Netherlands, Poland, Portugal, Spain and Sweden, and ongoing outbreaks or considerable increase are reported in Belgium (Flanders region), France, Romania. updates outside of EU/EEA are provided for Morocco and Viet Nam. No updates are provided for WHO regions.
Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to TESSy and EpiPulse. Data presented in the two monthly reports may differ.
Epidemiological summary for EU/EEA countries with relevant epidemic intelligence updates:
Austria reported 95 measles cases in 2025 and as of 7 May 2025, an increase of 17 cases since 9 April 2025. The most recent four cases were reported in week 17 in Vienna, Lower Austria and Burgenland. Relevant information was available for 87 cases, of which 25 were hospitalised (28.7%), including one patient being treated in intensive care unit. No outbreaks have been reported.
Belgium reported a steady increase of measles cases on 3 May 2025. In the region of Flanders 95 cases were reported in 2025, of which almost a half - 48 cases, have been reported only in April 2025. Antwerp province is mostly affected with 60 cases reported since the beginning of the year, of which 47 were not vaccinated. Mainly children 0–9 years of age are affected. Half were hospitalised and some treated in intensive care unit, according to media report. In response to the situation, vaccination strategy has been adapted to reach as many unvaccinated people as possible in Antwerp via general practitioners and hospitals; vaccination is organised in schools, including mobile vaccination teams, where cases have been detected aiming at unvaccinated children up to 12 years of age.
Czechia reported 10 cases in 2025 as of 2 May 2025.
France reported 427 cases of measles, including one death (immunocompromised person) from 1 January to 13 April 2025. Of these, 143 (33.5%) were either hospitalised or visited emergency room, including 9 patients treated in intensive care; 58 patients had complications; mostly affected are children 1–4 years (17%) and 15–19 years (10%), the highest incidence rate is seen in infants. Of the reported cases, 65 (15%) were imported cases with travel history to Morocco (29 cases), Romania (5), Italy (5), Viet Nam (5), UK (4), Switzerland (3), Guinea (3). The imported cases were associated with at least 12 clusters with 28 cases. Vaccination status was known for 304 cases, of which 68.4% were unvaccinated or had incomplete vaccination. The cases have been reported from 60 departments in mainland France (59.4% of all departments) and no measles cases have been reported in overseas territories. Most of the cases had genotype B3 ( 62.5%) and D8 (34.7%) (detected from samples of 72 cases). Among the samples from imported cases from Morocco (29), 15 strains were sequenced and are all genotype B3.
Germany reported 148 confirmed and probable measles cases in 2025 and as of 12 May 2025, an increase of 63 cases since 15 April 2025, of which nearly half (26 cases) were reported on week 19 2025.
Hungary reported three cases of measles in 2025 as of 4 May 2025.
Italy reported 227 cases from January to March 2025. Of the reported cases, 88.7% were not vaccinated, including 8 children not eligible for vaccination; 10.6% were imported cases; about a third had measles related complications. Transmission mostly occurred in families, though 21 healthcare workers acquired the infection. Of the 15 regions reporting measles cases, more than half of the cases are reported by four regions.
The Netherlands reported 375 measles cases in 2025 and as of 7 May 2025, an increase by 124 cases since 9 April 2025. There is no indication of a national outbreak. Clusters of measles cases have been detected among children linked to primary schools, with additional cases reported within households. In 2025, 30 cases were reported to have contracted measles in Morocco, three in Romania, and one in each, Vietnam, Belgium and Iran.
Poland reported 46 measles cases in 2025 and as of 30 April, an increase of 12 cases since 31 March 2025.
Portugal reported, according to media citing official sources, 19 measles cases in 2025, an increase of eight cases since previous report on 8 April 2025. Fourteen of the cases are adults, two thirds of whom are unvaccinated, other cases are unvaccinated children. According to another media source citing health authority, most of the cases are in Lisbon and Tagus regions, and at least one case is from Central region. All cases were imported or linked to an imported case.
Romania reported 6 401 measles cases and eight deaths in 2025 and as of 30 April, an increase of 1 297 cases, including four deaths since 31 March 2025. The recent deaths have been reported in four small children (under 2 years of age), all unvaccinated, three of whom due to underlying conditions and one due to age.
Spain reported 229 cases of measles as of 11 May 2025, of which 78 were imported and 78 related to imported cases.
Sweden reported six measles cases in 2025 and as of 14 May 2025.
Epidemiological summary for select countries outside of EU/EEA with relevant epidemic intelligence updates:
Morocco reports decreasing trend of measles cases for the ten consecutive weeks, following a catch-up vaccination campaign on a national level, according to WHO DON on 13 May 2025. B3 is the circulating genotype. WHO assesses the risk as medium in Morocco and in the region. There are no restrictions on travel or trade in Morocco due to this outbreak.
United States of America reported 1 001 confirmed measles cases, including three deaths in 31 jurisdictions in 2025 and as of 8 May. Of the reported cases, 93% were related to 14 outbreaks.
Viet Nam. On 18 March 2025, WHO jointly with UNICEF released a news statement on measles prevention efforts in Viet Nam. An ongoing outbreak of measles continues to affect central and northern Viet Nam with new outbreaks reported in areas. The national authorities are putting effective effort to respond to the outbreak. In the latest Measles-Rubella bulletin of the World Health Organization, Regional Office for the Western Pacific (WHO WPRO), Viet Nam reported 144 confirmed measles cases in period from January to March 2025. However, WHO indicated that according to the official Viet Nam’s Government newspaper, as of March 2025, there have been reported 38 807 suspected cases, of which 3 447 cases are positive to measles. So far, five deaths associated with measles have been reported in the country.
Summary of measles cases reported by WHO regional offices
No updates have been provided from WHO regional offices.
The numbers provided to WHO for EU/EEA countries are from TESSy data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.
ECDC assessment
The overall number of measles cases in the EU/EEA increased steadily between June 2023 and March 2024 before decreasing between April 2024 and February 2025. Measles cases may continue to increase in the EU/EEA in the coming months, in line with measles observed seasonality. This is due to reported suboptimal vaccination coverage for measles-containing vaccines (MCV) in a number of EU/EEA countries, as well as a high probability of importation from areas experiencing high circulation. The majority of recently reported cases have acquired the disease within the reported country through community/local transmission, however cases related to international travel have been reported.
Actions
ECDC is monitoring the measles situation through its epidemic intelligence activities, which supplement monthly outputs with measles surveillance data from TESSy, routinely submitted by 30 EU/EEA countries.
As the number of cases is expected to rise in the near future, ECDC urges EU/EEA public health authorities to focus on the following areas:
- Close immunity gaps, achieve and maintain high vaccination coverage for MCV (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
- Strive towards high-quality surveillance and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
- Increase the clinical awareness of health professionals, including reminding them of the importance of checking individuals' vaccination status ahead of travel.
- Healthcare professionals should be fully vaccinated.
- Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of suboptimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
- Address barriers and engage with under-served populations. Systemic barriers that impact vaccine uptake in under-served, isolated and difficult-to-reach populations need to be monitored and addressed with targeted strategies in order to reduce inequalities in vaccine uptake.
ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response', published in February 2024 and the conclusions remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.